FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 60 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,755 | -25.6% | 15,951 | +4.8% | 0.00% | – |
| Q2 2023 | $107,128 | -44.4% | 15,217 | -51.0% | 0.00% | – |
| Q1 2023 | $192,665 | -10.9% | 31,075 | -8.3% | 0.00% | – |
| Q4 2022 | $216,174 | +49.1% | 33,883 | +100.2% | 0.00% | – |
| Q3 2022 | $145,000 | -35.0% | 16,922 | +3.3% | 0.00% | – |
| Q2 2022 | $223,000 | +11.5% | 16,378 | +24.6% | 0.00% | – |
| Q1 2022 | $200,000 | -76.0% | 13,145 | -63.9% | 0.00% | – |
| Q4 2021 | $833,000 | +368.0% | 36,443 | +184.5% | 0.00% | – |
| Q3 2021 | $178,000 | -19.1% | 12,809 | +18.1% | 0.00% | – |
| Q4 2020 | $220,000 | – | 10,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,674,120 | $63,370,600 | 4.60% |
| Euclidean Capital LLC | 3,147,522 | $15,737,610 | 1.72% |
| Birchview Capital, LP | 264,843 | $1,324,215 | 1.13% |
| Artal Group S.A. | 1,720,720 | $8,604 | 0.37% |
| Rockwood Wealth Management, LLC | 214,677 | $1,073,385 | 0.18% |
| Alphabet Inc. | 500,901 | $2,504,505 | 0.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $3,887,625 | 0.09% |
| CORNERCAP INVESTMENT COUNSEL INC | 25,819 | $129,095 | 0.02% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 343,720 | $1,718,600 | 0.02% |
| WADE G W & INC | 107,770 | $539 | 0.02% |